secwatch.observer — SEC 8-K summary
======================================

Issuer:     KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU)
CIK:        0000055529
Form:       8-K
Filed at:   2024-09-11T23:59:59+00:00
Accession:  0000055529-24-000027
Event type: earnings
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kewaunee Scientific Q1 FY2025 sales down 2.9%, EPS $0.74 vs $0.86, backlog up 13%
--------------------------------------------------------------------------------

- Sales $48.4M, down 2.9% YoY; diluted EPS $0.74 vs $0.86 in prior year quarter.
- Domestic net earnings rose to $2.9M from $2.7M; International sales fell 10.7% due to India site delays.
- Order backlog grew to $159.4M from $140.8M a year ago (+13%).
- Adjusted EBITDA (excl. professional fees) $4.1M; professional fees unrelated to core business increased.
- Management sees strong backlog and quoting activity for another strong year.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/55529/000005552924000027/0000055529-24-000027-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/55529/000005552924000027/kequ-20240911.htm
  HTML page:      https://secwatch.observer/filing/0000055529-24-000027

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer